In this video, Jacqueline Garcia, MD, Dana-Farber Cancer Institute, Boston, MA, highlights the importance of novel immune therapy approaches in myelodysplastic syndromes (MDS), and further comments on upcoming clinical trials investigating these approaches. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.